MassMutual Private Wealth & Trust’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.14K Sell
93
-91
-49% -$3.59K ﹤0.01% 1789
2026
Q2
$7.09K Hold
184
– – ﹤0.01% 1546
2026
Q1
$4.57K Hold
184
– – ﹤0.01% 1714
2025
Q4
$4.68K Buy
184
+40
+28% +$892 ﹤0.01% 1699
2025
Q3
$2.32K Buy
144
+135
+1,500% +$2.19K ﹤0.01% 1942
2025
Q2
$144 Sell
9
-159
-95% -$2.4K ﹤0.01% 2312
2025
Q1
$2.87K Buy
+168
New +$3.51K ﹤0.01% 1808
2021
Q2
– Sell
-26
Closed – – 1251
2021
Q1
$0 Buy
+26
New +$686 ﹤0.01% 1142

Other funds holding IMVT

MassMutual Private Wealth & Trust's IMVT Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Immunovant (IMVT) stake by 49% in Q3 2026, selling an estimated $3.59K and leaving 93 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

MassMutual Private Wealth & Trust first reported a position in IMVT in Q1 2021 and has held it in 8 quarters since. The position peaked at $7.09K in Q2 2026. 223 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • MassMutual Private Wealth & Trust held 93 shares of Immunovant worth $3.14K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 91 Immunovant shares in Q3 2026, an estimated $3.59K.
  • Immunovant made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1789 holding.
  • MassMutual Private Wealth & Trust first reported a position in Immunovant in Q1 2021 and has held it in 8 quarters since.
  • MassMutual Private Wealth & Trust's Immunovant position peaked at $7.09K in Q2 2026.
  • 223 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.